MedTrace Logo

Nutritional Counselling for Patients at Kasr AlAiny Multiple Sclerosis Clinic: an Intervention Study

NCT04217564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-07-22

No results posted yet for this study

Summary

Eligible Multiple sclerosis patients attending Kasr AlAiny Multiple Sclerosis Clinic will be randomly allocated to either the intervention or control group by randomized block design.

Patients in the 2 groups will be initially assessed. Those in the intervention group will receive a counselling session then instructed on the subsequent follow up dates. Those in the control group will not receive nutritional counselling during the study period but will be instructed to attend for final assessment by the end of the study. Apart from counselling, patients will receive the same care from the clinic medical staff. After the final assessment the control group will be invited to receive the nutritional counselling material to gain its suspected benefits.

Conditions

Interventions

BEHAVIORAL

Nutritional counselling

Nutritional counselling based on the nutritional assessment will be conducted. A booklet that contains the whole instructions and dietary records will be provided to help remembering information and record their application of the plan.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Prof. Zeinab Emam Mohamed Afifi, MD · Cairo University

  • Prof. Nebal Abdel Rahman Aboul-Ella, MD · Egyptian National Nutrition Institute

  • Associate professor. Amr Hassan, MD · Cairo University

  • Dr. Marwa Rashad Salem, MD · Cairo University

  • Dr. Asmaa Farrag El-Sayed Othman, Msc · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-03-18
Completion
2020-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04217564 on ClinicalTrials.gov